Naomi Fuller
Biographic Data
| ID | 9801383 |
|---|---|
| NAME | Naomi Fuller |
| GIVEN NAMES | Naomi |
| FAMILY NAME | Fuller |
| SIGNATURE | FULLER N |
| AFFILIATIONS | London School of Hygiene & Tropical Medicine |
| ORCID | 0000-0003-4026-5591 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines
INTRODUCTION: Antibiotic resistance (ABR) may increase hospital costs, utility loss and mortality risk per patient. Understanding these losses at national, regional and global scales is necessary for efficiently tackling ABR. Our aim is to estimate the global economic burden of antibiotic-resistant infections and the potential for bacterial vaccines to mitigate this burden. METHODS: We take healthcare system and labour productivity perspectives. …
No prominent works on this page.
The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines
INTRODUCTION: Antibiotic resistance (ABR) may increase hospital costs, utility loss and mortality risk per patient. Understanding these losses at national, regional and global scales is necessary for efficiently tackling ABR. Our aim is to estimate the global economic burden of antibiotic-resistant infections and the potential for bacterial vaccines to mitigate this burden. METHODS: We take healthcare system and labour productivity perspectives. …
Antibiotic resistance (1 works) · Antibiotic Resistance in Bacteria (1 works) · Antibiotic Use and Resistance (1 works) · Antibiotics (1 works) · Antibiotics Pharmacokinetics and Efficacy (1 works) · Business (1 works) · Economic cost (1 works) · Economic growth (1 works) · Economic impact analysis (1 works) · Economics (1 works)